Nordea Investment Management AB Reduces Stake in Maximus, Inc. $MMS

Nordea Investment Management AB lowered its stake in Maximus, Inc. (NYSE:MMS) by 15.3% in the 4th quarter, Holdings Channel reports. The firm owned 55,183 shares of the health services provider’s stock after selling 10,003 shares during the quarter. Nordea Investment Management AB’s holdings in Maximus were worth $4,811,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Richardson Financial Services Inc. lifted its holdings in shares of Maximus by 123.1% in the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after buying an additional 192 shares in the last quarter. Advisory Services Network LLC purchased a new position in Maximus during the third quarter valued at approximately $32,000. Cullen Frost Bankers Inc. bought a new stake in Maximus during the 3rd quarter worth approximately $38,000. Canada Pension Plan Investment Board purchased a new stake in Maximus in the 2nd quarter worth approximately $35,000. Finally, Danske Bank A S purchased a new stake in Maximus in the 3rd quarter worth approximately $55,000. 97.21% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

MMS has been the subject of a number of recent analyst reports. Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy”.

Maximus Stock Down 2.6%

MMS stock opened at $66.03 on Friday. The company’s 50 day moving average is $79.89 and its 200 day moving average is $84.49. The stock has a market cap of $3.60 billion, a price-to-earnings ratio of 10.05 and a beta of 0.59. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 1-year low of $64.68 and a 1-year high of $100.00.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period in the previous year, the business posted $1.61 earnings per share. Maximus’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. This is an increase from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is presently 20.09%.

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 742 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total transaction of $53,609.50. Following the sale, the director owned 20,795 shares in the company, valued at $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bruce Caswell purchased 3,175 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were purchased at an average cost of $78.45 per share, with a total value of $249,078.75. Following the purchase, the chief executive officer owned 328,013 shares of the company’s stock, valued at approximately $25,732,619.85. The trade was a 0.98% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 1.80% of the stock is owned by company insiders.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.